GlassScriptPhysician profile
Richard B Jamison
NPI 1982604757
$1,499.82
in general payments reported to CMS, 2019-2025
34 companies · $22.97 in 2025
The $22.97 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $131 · 2021: $29.06 · 2022: $379 · 2023: $420 · 2024: $220 · 2025: $22.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $248.59 | 2022-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $204.99 | 2019-2024 | |
| Abbvie INC. | $115.76 | 2019-2023 | |
| Hologic Sales and Service, LLC | $110.07 | 2019-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Myriad Women'S Health, INC. | $84.20 | 2023 | Myrisk |
| Dysis Medical, INC. | $75.91 | 2020 | |
| Therapeuticsmd, INC. | $50.13 | 2019 | |
| Merck Sharp & Dohme LLC | $48.36 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $42.64 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $38.89 | 2019 | |
| Baxter Healthcare | $38.35 | 2022 | |
| Kci USA, INC. | $36.33 | 2019-2022 | |
| Amgen INC. | $34.32 | 2019 | |
| Coopersurgical, INC. | $33.83 | 2023-2024 | Summit Doppler |
| Ethicon US, LLC | $30.56 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $28.55 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $27.02 | 2021-2023 | Balcoltra |
| Millicent US INC | $22.77 | 2024 | Intrarosa |
| Sumitomo Pharma America, INC. | $20.87 | 2023 | Myfembree |
| Smith+Nephew, INC. | $18.30 | 2024 | Pico 14 |
| Avanos Medical | $18.24 | 2019 | |
| Mylan Pharmaceuticals INC. | $17.62 | 2022 | |
| Allergan, INC. | $17.04 | 2019 | |
| Evofem Biosciences, INC. | $16.83 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.24 | 2023 | |
| Exact Sciences Corporation | $14.70 | 2023 | Cologuard Collection Kit |
| Myovant Sciences INC. | $14.55 | 2022 | |
| Coloplast Corp | $14.25 | 2022 | |
| Scynexis, INC. | $14.19 | 2022 | |
| Mayne Pharma Commercial LLC | $13.95 | 2022 | |
| Lupin INC. | $13.35 | 2019 | |
| Aspira Women'S Health INC | $11.82 | 2019 | |
| Organon LLC | $7.60 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Jamison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.